semaglutide 75 units FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products ReCET procedure plus semaglutide may

Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF

Negligent misrepresentation: Lawsuits accuse Novo Nordisk of overstating the potential benefits of Ozempic while minimizing or obscuring some of its risks

The same holds for the newest drugs in the pipeline, including CagriSema, retatrutide and the Chinese-developed mazdutide, whose weight-loss numbers rival tirzepatides but whose long-term risk data is not yet in

Some examples of risks of compounded semaglutide include dosing errors and contamination, which can lead to serious side effects